The effects of exercise and supplement on infertile women with PCOS

The effect of high-intensity interval training and nanocurcumin consumption of microRNAs(miRNA) 29a-5P, 93 and Anti Mullerian Hormone(AMH) in infertile women with polycystic ovary syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231217060434N1

Enrollment

Registered

2024-01-26

Start date

2024-02-20

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Polycystic ovary syndrome. Condition 2: Female infertility. Polycystic ovarian syndrome Female infertility

Interventions

Intervention 1: Intervention group 1: exercise-supplement. Subjects of the exercise-supplement group take one 80 mg capsule of nanocurcumin with a daily dose during the period.

Eligibility

Sex/Gender

Female

Age

20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Infertile women Women with PCOS Age between 20 and 38 years (fertility age)

Exclusion criteria

Exclusion criteria: Cardiovascular disease Respiratory disease Using hormonal drugs

Design outcomes

Primary

Measure	Time frame
MicroRNA 29a-5P. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.;Anti Mullerian Hormone. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.;MicroRNA 93. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.	—

Measure

Time frame

MicroRNA 29a-5P. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.;Anti Mullerian Hormone. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.;MicroRNA 93. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: blood test.

—

Secondary

Measure	Time frame
Body Mass Index. Timepoint: before the start of the intervention and 3 months after the intervention at the end of the work. Method of measurement: BMI formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir hossain Delshad

The University of Qom

ah_delshad@yahoo.com+98 25 3210 3693

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026